Target
Human PD-L2 / PDCD1LG2 / CD273
Synonyms
PDCD1LG2 | B7 dendritic cell molecule | B7-DC | B7DC | BA574F11.2 | CD273 | Btdc | CD273 antigen | PD-L2 | PDCD1 ligand 2 | PD-1-ligand 2 | Programmed death ligand 2 | Butyrophilin B7-DC | PD-1 ligand 2 | PDCD1L2 | PDL2
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG2a,k
Monoclonal
Conjugations
Unconjugated
Purification
Protein A purified
Immunogen
Recombinant human CD273(B7-DC).
Specificity
Antibody ANC8D12 binds to recombinant CD273 and cell surface CD273 expressed on monocyte derived Dendritic cells (moDC), and blocks binding of recombinant CD279 to CD273 in EIA and FACS.
Applications
- Flow Cytometry
- ELISA
- Blocking
Usage
Human monocyte derived Dendritic cells were prepared in 8 day culture. Five x 105 cells per tube were washed and incubated 45 minutes on ice with 80 ul of anti-human CD273 antibody at concentration of 5 ug/ml. They were then washed twice and incubated with Goat-anti-Mouse/FITC, after which they were washed twice, fixed and analyzed by FACS. Cells stained positive with a mean shift of 0.9 log10 fluorescent units when compared to isotype control Mouse IgG2a antibody. Binding was blocked when reagent was pre incubated with a 10-fold excess of recombinant CD273- muIg.
Presentation
50 mM Sodium Phosphate, pH 7.5, 150 mM NaCl, 100 mM KCl
Storage
Store at 4°C. Do not freeze. Open under aseptic conditions.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About PD-L2 / PDCD1LG2 / CD273